Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ohlén

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Cutting edge: myelin basic protein-specific cytotoxic T cell tolerance is maintained in vivo by a single dominant epitope in H-2k miceE S Huseby, C Ohlén, J Goverman
The Journal of Experimental Medicine|February 1, 1994
The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class IR Glas, C Ohlén, P Höglund, et al.
Immunology Today|August 1, 1992
Allorecognition by NK cells: nonself or no self?L Moretta, E Ciccone, A Moretta, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
The RMA-S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejectionH G Ljunggren, C Ohlén, P Höglund, et al.
Cellular Immunology|May 1, 1989
Enhanced H-2 expression and T-cell-dependent rejection after intracerebral transplantation of the murine lymphoma YAC-1T Yamasaki, H G Ljunggren, C Ohlén, et al.
The Journal of Experimental Medicine|August 1, 1991
Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the targetP Höglund, R Glas, C Ohlén, et al.
Nature|October 20, 1994
Source of unique tumour antigensA Townsend, C Ohlén, M Rogers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Expression of a tolerizing tumor antigen in peripheral tissue does not preclude recovery of high-affinity CD8+ T cells or CTL immunotherapy of tumors expressing the antigenC Ohlén, M Kalos, D J Hong, et al.
The Journal of Experimental Medicine|September 6, 2001
A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosisE S Huseby, D Liggitt, T Brabb, et al.
International Journal of Cancer|October 15, 1989
Effect of IFN-gamma treatment and in vivo passage of murine tumor cell lines on their sensitivity to lymphokine-activated killer (LAK) cell lysis in vitro; association with H-2 expression on the target cellsL Tsai, C Ohlén, H G Ljunggren, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Cutting edge: myelin basic protein-specific cytotoxic T cell tolerance is maintained in vivo by a single dominant epitope in H-2k miceE S Huseby, C Ohlén, J Goverman
The Journal of Experimental Medicine|February 1, 1994
The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class IR Glas, C Ohlén, P Höglund, et al.
Immunology Today|August 1, 1992
Allorecognition by NK cells: nonself or no self?L Moretta, E Ciccone, A Moretta, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
The RMA-S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejectionH G Ljunggren, C Ohlén, P Höglund, et al.
Cellular Immunology|May 1, 1989
Enhanced H-2 expression and T-cell-dependent rejection after intracerebral transplantation of the murine lymphoma YAC-1T Yamasaki, H G Ljunggren, C Ohlén, et al.
The Journal of Experimental Medicine|August 1, 1991
Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the targetP Höglund, R Glas, C Ohlén, et al.
Nature|October 20, 1994
Source of unique tumour antigensA Townsend, C Ohlén, M Rogers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Expression of a tolerizing tumor antigen in peripheral tissue does not preclude recovery of high-affinity CD8+ T cells or CTL immunotherapy of tumors expressing the antigenC Ohlén, M Kalos, D J Hong, et al.
The Journal of Experimental Medicine|September 6, 2001
A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosisE S Huseby, D Liggitt, T Brabb, et al.
International Journal of Cancer|October 15, 1989
Effect of IFN-gamma treatment and in vivo passage of murine tumor cell lines on their sensitivity to lymphokine-activated killer (LAK) cell lysis in vitro; association with H-2 expression on the target cellsL Tsai, C Ohlén, H G Ljunggren, et al.
Pageof 3